Immutep Ltd Adr Stock Operating Margin

IMMP Stock

USD 1.93 0.09 4.89%

Immutep Ltd ADR fundamentals help investors to digest information that contributes to Immutep's financial success or failures. It also enables traders to predict the movement of Immutep Stock. The fundamental analysis module provides a way to measure Immutep's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immutep stock.

		Last Reported	Projected for Next Year
	Operating Profit Margin	(14.74)	(15.48)

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Immutep Ltd ADR Company Operating Margin Analysis

Immutep's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

Operating Income

Revenue

100

More About Operating Margin | All Equity Analysis

Current Immutep Operating Margin

(13.53) %

Most of Immutep's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immutep Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Immutep Operating Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for Immutep is extremely important. It helps to project a fair market value of Immutep Stock properly, considering its historical fundamentals such as Operating Margin. Since Immutep's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Immutep's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Immutep's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Short Term Investments	Common Stock	Property Plant Equipment	Net Tangible Assets	Current Deferred Revenue	Long Term Debt	Good Will	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		1.0	-0.99	-0.82	0.57	0.83	0.34	0.99	-0.02	-0.31	0.56	0.81	0.15	0.97	0.61	-0.23	-0.8	0.56	0.95	0.96	0.83
Total Stockholder Equity	1.0		-0.99	-0.79	0.57	0.81	0.28	1.0	-0.07	-0.27	0.58	0.8	0.18	0.98	0.57	-0.29	-0.8	0.51	0.96	0.96	0.83
Net Debt	-0.99	-0.99		0.77	-0.62	-0.82	-0.25	-0.99	0.13	0.26	-0.61	-0.84	-0.24	-0.99	-0.54	0.33	0.75	-0.51	-0.97	-0.97	-0.87
Retained Earnings	-0.82	-0.79	0.77		-0.46	-0.88	-0.74	-0.77	-0.42	0.6	-0.33	-0.83	0.17	-0.72	-0.9	-0.29	0.52	-0.89	-0.78	-0.79	-0.72
Accounts Payable	0.57	0.57	-0.62	-0.46		0.57	0.29	0.59	-0.23	0.17	0.46	0.64	0.61	0.59	0.13	-0.33	-0.15	0.26	0.58	0.59	0.61
Net Receivables	0.83	0.81	-0.82	-0.88	0.57		0.58	0.81	0.12	-0.53	0.55	0.85	-0.03	0.81	0.76	0.07	-0.49	0.8	0.88	0.89	0.85
Total Liab	0.34	0.28	-0.25	-0.74	0.29	0.58		0.26	0.6	-0.6	-0.04	0.51	-0.39	0.18	0.77	0.72	-0.09	0.84	0.25	0.28	0.25
Total Current Assets	0.99	1.0	-0.99	-0.77	0.59	0.81	0.26		-0.14	-0.24	0.61	0.79	0.23	0.98	0.54	-0.31	-0.81	0.49	0.95	0.95	0.83
Intangible Assets	-0.02	-0.07	0.13	-0.42	-0.23	0.12	0.6	-0.14		-0.48	-0.5	0.1	-0.7	-0.2	0.54	0.64	0.07	0.48	-0.09	-0.08	-0.1
Short Term Debt	-0.31	-0.27	0.26	0.6	0.17	-0.53	-0.6	-0.24	-0.48		0.03	-0.44	0.74	-0.26	-0.85	-0.63	0.16	-0.81	-0.32	-0.34	-0.31
Short Term Investments	0.56	0.58	-0.61	-0.33	0.46	0.55	-0.04	0.61	-0.5	0.03		0.5	0.48	0.66	0.15	-0.34	-0.32	0.23	0.63	0.63	0.63
Common Stock	0.81	0.8	-0.84	-0.83	0.64	0.85	0.51	0.79	0.1	-0.44	0.5		0.1	0.81	0.65	-0.06	-0.36	0.75	0.84	0.85	0.9
Property Plant Equipment	0.15	0.18	-0.24	0.17	0.61	-0.03	-0.39	0.23	-0.7	0.74	0.48	0.1		0.25	-0.49	-0.66	0.0	-0.39	0.17	0.16	0.21
Net Tangible Assets	0.97	0.98	-0.99	-0.72	0.59	0.81	0.18	0.98	-0.2	-0.26	0.66	0.81	0.25		0.5	-0.37	-0.74	0.47	0.97	0.97	0.87
Current Deferred Revenue	0.61	0.57	-0.54	-0.9	0.13	0.76	0.77	0.54	0.54	-0.85	0.15	0.65	-0.49	0.5		0.57	-0.38	0.95	0.56	0.58	0.51
Long Term Debt	-0.23	-0.29	0.33	-0.29	-0.33	0.07	0.72	-0.31	0.64	-0.63	-0.34	-0.06	-0.66	-0.37	0.57		0.24	0.58	-0.3	-0.27	-0.27
Good Will	-0.8	-0.8	0.75	0.52	-0.15	-0.49	-0.09	-0.81	0.07	0.16	-0.32	-0.36	0.0	-0.74	-0.38	0.24		-0.21	-0.69	-0.68	-0.44
Long Term Debt Total	0.56	0.51	-0.51	-0.89	0.26	0.8	0.84	0.49	0.48	-0.81	0.23	0.75	-0.39	0.47	0.95	0.58	-0.21		0.55	0.57	0.57
Net Invested Capital	0.95	0.96	-0.97	-0.78	0.58	0.88	0.25	0.95	-0.09	-0.32	0.63	0.84	0.17	0.97	0.56	-0.3	-0.69	0.55		1.0	0.94
Net Working Capital	0.96	0.96	-0.97	-0.79	0.59	0.89	0.28	0.95	-0.08	-0.34	0.63	0.85	0.16	0.97	0.58	-0.27	-0.68	0.57	1.0		0.94
Capital Stock	0.83	0.83	-0.87	-0.72	0.61	0.85	0.25	0.83	-0.1	-0.31	0.63	0.9	0.21	0.87	0.51	-0.27	-0.44	0.57	0.94	0.94

Click cells to compare fundamentals

A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.

Competition

Predict Immutep

Operating Profit Margin Over Time

Immutep Pretax Profit Margin

Pretax Profit Margin

(13.74)

At this time, Immutep's Pretax Profit Margin is relatively stable compared to the past year.

Based on the recorded statements, Immutep Ltd ADR has an Operating Margin of -13.5342%. This is 61.42% lower than that of the Biotechnology sector and 87.92% lower than that of the Health Care industry. The operating margin for all United States stocks is 145.63% higher than that of the company.

Immutep Current Valuation Drivers

We derive many important indicators used in calculating different scores of Immutep from analyzing Immutep's financial statements. These drivers represent accounts that assess Immutep's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Immutep's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	61.8M	310.2M	229.8M	257.6M	296.2M	294.6M
Enterprise Value	44.5M	252.9M	151.6M	135.4M	155.7M	264.1M

Immutep Fundamentals

	Return On Equity	-0.26
	Return On Asset	-0.17
	Operating Margin	(13.53) %
	Current Valuation	152.51 M
	Shares Outstanding	145.46 M
	Shares Owned By Insiders	0.01 %
	Shares Owned By Institutions	6.27 %
	Number Of Shares Shorted	5.01 M
	Price To Earning	(152.55) X
	Price To Book	2.17 X
	Price To Sales	75.17 X
	Revenue	3.84 M
	Gross Profit	(32.75 M)
	EBITDA	(44.54 M)
	Net Income	(42.72 M)
	Cash And Equivalents	80 M
	Cash Per Share	0.92 X
	Total Debt	1.59 M
	Debt To Equity	0.02 %
	Current Ratio	14.16 X
	Book Value Per Share	0.13 X
	Cash Flow From Operations	(34.82 M)
	Short Ratio	62.14 X
	Earnings Per Share	(0.23) X
	Target Price	9.5
	Beta	1.92
	Market Capitalization	288.78 M
	Total Asset	201.58 M
	Retained Earnings	(382.65 M)
	Working Capital	125.19 M
	Current Asset	1.89 M
	Current Liabilities	1.04 M
	Net Asset	201.58 M

About Immutep Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Immutep Ltd ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immutep using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immutep Ltd ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Immutep

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immutep position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will appreciate offsetting losses from the drop in the long position's value.

Moving together with Immutep Stock

0.63	ME	23Andme Holding	Pair Corr
0.79	VALN	Valneva SE ADR	Pair Corr
0.63	JNJ	Johnson Johnson Sell-off Trend	Pair Corr

Moving against Immutep Stock

0.74	KZR	Kezar Life Sciences	Pair Corr
0.7	MLYS	Mineralys Therapeutics,	Pair Corr
0.33	MDGL	Madrigal Pharmaceuticals	Pair Corr

The ability to find closely correlated positions to Immutep could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immutep when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immutep - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immutep Ltd ADR to buy it.

The correlation of Immutep is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immutep moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immutep Ltd ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Immutep can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Immutep Stock Analysis

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC